P27 and P53 Gene Polymorphisms and Restenosis following Coronary Implantation of Drug-Eluting Stents

Publisher： Karger

E-ISSN： 1421-9751|112|4|263-269

ISSN： 0008-6312

Source： Cardiology, Vol.112, Iss.4, 2008-08, pp. : 263-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended follow‐up following “full‐metal jacket” percutaneous coronary interventions with drug‐eluting stents

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1042-1050

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distal Left Main Coronary Bifurcation Lesions Predict Worse Outcome in Patients Undergoing Percutaneous Implantation of Drug-Eluting Stents: Results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study

By  

Cardiology, Vol. 113, Iss. 4, 2009-02 ,pp. : 264-273

Karger

Access to resources Recommend Favorite

Clinical outcome of patients with implantation of second‐generation drug‐eluting stents in the right coronary ostium: Insights from 2‐year follow‐up of the TWENTE trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 524-531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of high lipoprotein(a) levels on in‐stent restenosis and long‐term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug‐eluting stents in Asian population

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 6, 2015-06 ,pp. : 588-595

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioresorbable drug‐eluting scaffold restenosis

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 7, 2015-06 ,pp. : 1162-1163

John Wiley & Sons Inc

Access to resources Recommend Favorite